768 related articles for article (PubMed ID: 33571819)
1. Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review.
Alamri RD; Elmeligy MA; Albalawi GA; Alquayr SM; Alsubhi SS; El-Ghaiesh SH
Int Immunopharmacol; 2021 Apr; 93():107398. PubMed ID: 33571819
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review.
Kaur H; Sarma P; Bhattacharyya A; Sharma S; Chhimpa N; Prajapat M; Prakash A; Kumar S; Singh A; Singh R; Avti P; Thota P; Medhi B
Eur J Pharmacol; 2021 Sep; 906():174233. PubMed ID: 34111397
[TBL] [Abstract][Full Text] [Related]
3. A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial.
Hu K; Wang M; Zhao Y; Zhang Y; Wang T; Zheng Z; Li X; Zeng S; Zhao D; Li H; Xu K; Lan K
Virol Sin; 2020 Dec; 35(6):725-733. PubMed ID: 32696396
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
[TBL] [Abstract][Full Text] [Related]
5. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
[TBL] [Abstract][Full Text] [Related]
6. Dihydroorotate dehydrogenase inhibitors in SARS-CoV-2 infection.
Coelho AR; Oliveira PJ
Eur J Clin Invest; 2020 Oct; 50(10):e13366. PubMed ID: 32735689
[No Abstract] [Full Text] [Related]
7. Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Breedveld FC; Dayer JM
Ann Rheum Dis; 2000 Nov; 59(11):841-9. PubMed ID: 11053058
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
Goldenberg MM
Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis.
Alfaro-Lara R; Espinosa-Ortega HF; Arce-Salinas CA;
Reumatol Clin (Engl Ed); 2019; 15(3):133-139. PubMed ID: 28867467
[TBL] [Abstract][Full Text] [Related]
10. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
11. Suppression of pyrimidine biosynthesis by targeting DHODH enzyme robustly inhibits rotavirus replication.
Chen S; Ding S; Yin Y; Xu L; Li P; Peppelenbosch MP; Pan Q; Wang W
Antiviral Res; 2019 Jul; 167():35-44. PubMed ID: 30974126
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Intramolecular Hydrogen Bond on the Active Metabolite Analogs of Leflunomide for Blocking the Plasmodium falciparum Dihydroorotate Dehydrogenase Enzyme: QTAIM, NBO, and Docking Study.
Heidarian R; Zahedi-Tabrizi M
Curr Comput Aided Drug Des; 2021; 17(3):480-491. PubMed ID: 32459610
[TBL] [Abstract][Full Text] [Related]
13. The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study.
Muehler A; Kohlhof H; Groeppel M; Vitt D
Drugs R D; 2019 Dec; 19(4):351-366. PubMed ID: 31621054
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Coronavirus Disease 2019 Patients With Prolonged Postsymptomatic Viral Shedding With Leflunomide: A Single-center Randomized Controlled Clinical Trial.
Wang M; Zhao Y; Hu W; Zhao D; Zhang Y; Wang T; Zheng Z; Li X; Zeng S; Liu Z; Lu L; Wan Z; Hu K
Clin Infect Dis; 2021 Dec; 73(11):e4012-e4019. PubMed ID: 32955081
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide: efficacy and safety in clinical trials for the treatment of rheumatoid arthritis.
Schiff MH; Strand V; Oed C; Loew-Friedrich I
Drugs Today (Barc); 2000 Jun; 36(6):383-94. PubMed ID: 12861359
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
Herrmann ML; Schleyerbach R; Kirschbaum BJ
Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
Chen X; Guo H; Qiu L; Zhang C; Deng Q; Leng Q
Front Immunol; 2020; 11():2056. PubMed ID: 32973814
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity.
Sanders S; Harisdangkul V
Am J Med Sci; 2002 Apr; 323(4):190-3. PubMed ID: 12003373
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action for leflunomide in rheumatoid arthritis.
Fox RI; Herrmann ML; Frangou CG; Wahl GM; Morris RE; Strand V; Kirschbaum BJ
Clin Immunol; 1999 Dec; 93(3):198-208. PubMed ID: 10600330
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide: A promising drug with good antitumor potential.
Zhang C; Chu M
Biochem Biophys Res Commun; 2018 Feb; 496(2):726-730. PubMed ID: 29357281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
